< Back to previous page
Researcher
Chantal Mathieu
- Disciplines:Endocrinology and metabolic diseases
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 75
- Continuous glucose monitoring for women with gestational diabetes: a randomized controlled trial: the CORDELIA studyFrom1 Jan 2024 → 29 Mar 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease InterceptionFrom1 Nov 2023 → TodayFunding: Horizon Europe - Digital, Industry and Space
- Quality of diabetes care: the role of health dataFrom29 Mar 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Neutrophils: neglected as potential players in autoimmune type 1 diabetes initiation, progression, and perpetuationFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Innovative strategies for screening, diagnosis and prevention of type 1 diabetes.From13 Dec 2022 → 15 Dec 2022Funding: BOF - various
- "SyneRegIm": exploring the SYNErgistic effect of β-cell REGeneration and emerging IMmune intervention strategies to prevent and/or reverse type 1 diabetesFrom1 Sep 2022 → TodayFunding: Foreign private sponsor - undefined
- The SERENA study: Semaglutide for the treatment of glucose intolerance in women with prior gestational diabetes: a double blind RCTFrom30 Aug 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Characterization of the dynamic immunophenotype during type 1 diabetes progression to identify predictive biomarkers of anti-CD3 mono- and combination therapy in disease prevention and reversal in miceFrom7 Aug 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Next-generation, multi-technology immune-monitoring and easy-access spectral flow cytometryFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
Publications
31 - 40 of 713
- NET Proteome in Established Type 1 Diabetes Is Enriched in Metabolic Proteins(2023)
Authors: Samal Bissenova, Rita Derua, Chantal Mathieu, Conny Gysemans, Lut Overbergh
- Orale semaglutide: een nieuwe en eerste orale GLP1-receptoragonist(2023)
Authors: Chantal Mathieu, Ann Mertens
Pages: 392 - 401 - Change in carbohydrate intake one year after Roux-en-Y gastric bypass: A prospective study.(2023)
Authors: Veerle Foulon, Patrick Augustijns, Matthias Lannoo, Ellen Deleus, Ann Meulemans, Chantal Mathieu, Ann Mertens, Christophe Matthys, Bart Van Der Schueren, Roman Vangoitsenhoven
Pages: 2601060231 - Applying the WHO global targets for diabetes mellitus(2023)
Authors: Chantal Mathieu
Pages: 194 - 200 - Sustained Impact of Intermittently Scanned Continuous Glucose Monitoring on Treatment Satisfaction and Severe Hypoglycemia in Adults with Type 1 Diabetes (FUTURE): An Analysis in People with Normal and Impaired Awareness of Hypoglycemia(2023)
Authors: Chantal Mathieu, Pieter Gillard
Pages: 231 - 241 - Exploring the use of continuous glucose monitoring to improve glycemic control and quality of life in type 1 diabetes(2023)
Authors: Pieter Gillard, Chantal Mathieu
- Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial - study protocol(2023)
Authors: Kaat Beunen, Annouschka Laenen, Pieter Gillard, Chantal Mathieu, Katrien Fouzia Benhalima
- CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes(2023)
Authors: Chantal Mathieu
- The changing landscape of scientific communication at EASD(2023)
Authors: Chantal Mathieu
Pages: 413 - 414 - Low Gestational Weight Gain in Women With Gestational Diabetes Is Safe With Better Metabolic Profile Postpartum(2023)
Authors: Caro Minschart, Johan Verhaeghe, Annouschka Laenen, Roland Devlieger, Chantal Mathieu, Katrien Fouzia Benhalima
Pages: 665 - 679
Patents
1 - 6 of 6
- Biomarkers for diabetes therapy (Inventor)
- Biomarkers for diabetes therapy (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- Citrullinated peptides for diagnosis or treatment of diabetes (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- RESISTANCE TO OXIDATIVE STRESS (Inventor)